Contact us for more information or to book your assessment visit!
Find the specialized Gondola® Partner Center nearest you and book an appointment to assess your treatment response.
Every October 29, the world comes together for World Stroke Day, raising awareness about strokes’ prevalence, consequences, prevention, and treatment. This article explores World Stroke Day 2023’s significance, history, current stroke rates, and the role of innovative therapies like Gondola AMPS in stroke management.
Parkinson’s disease has long been the subject of intense research in the field of medicine, with limited treatment options and a complex understanding of its origins. However, a recent study has shed new light on this neurodegenerative condition.
Recently a clinical study on fall prevention led by the University of Limerick was approved, and now they’re starting to …
Discover the Gondola Home device for self-administered AMPS therapy, designed to empower patients to take control of their treatment in the comfort of their own homes.
Today, we are happy to introduce Gondola® Professional, a version of our device specifically designed to be used by trained healthcare professionals for outpatient or in-hospital use.
We’re glad to announce that we’re joining the AgeingFit event this year, which is taking place in Lille in France.
Mauro Santinato has been part of the Dream Team for more than one year as Head of Production and Supply Chain, and last week he dedicated some of his time to talk with us.
We are thrilled to announce the appointment of our Scientific Advisory Board (SAB), whose mission is to provide guidance and scientific input on multiple aspects of our clinical activities as well as technology development of Gondola® Automated Mechanical Peripheral Stimulation (AMPS).
At Gondola, we aim to provide accessible therapy from the comfort of your home, especially in light of the challenges posed by the COVID-19 pandemic.
